Systolic Heart Failure Clinical Trial
Official title:
Single Dose of Nitrate-rich Beetroot Juice Does Not Improve Steady State Oxygen Consumption or Six-minute Walk Distance in Patients With Systolic Heart Failure.
Verified date | August 2014 |
Source | Brooke Army Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
Nitrate-rich beetroot juice supplementation has demonstrated reduced oxygen consumption and
submaximal exercise performance in healthy adults. Investigation for similar effects in
patients with heart failure has not previously been conducted.
This was a randomized, double-blind, placebo controlled trial. Following ingestion of the
active agent or placebo, subjects with systolic heart failure underwent submaximal steady
state exercise with gas exchange analysis followed thirty minutes later by a six minute walk
test. Second testing sessions were performed ten days.
There were no significant differences in the treatment and placebo arms in average oxygen
consumption or six minute walk distance.
In conclusion, in patients with heart failure who have ingested a single dose of
nitrate-rich beetroot juice concentrate, there is no significant difference with regard to
oxygen consumption during submaximal steady state exercise or six minute walk testing
distance.
Further study is warranted to determine the true efficacy of nitrate consumption in this
population with adjustments in acute or chronic dosing, exercise duration, or intensity.
Status | Completed |
Enrollment | 12 |
Est. completion date | May 2014 |
Est. primary completion date | May 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Local institutional beneficiaries between the ages of 18 and 80 - Documentation of left ventricular systolic dysfunction with ejection fraction < 40% by any modality within the past six months - Documentation of New York Heart Association class II or III status. Exclusion Criteria: - > 80 years of age - Unable to adequately or safely perform treadmill exercise - Pulmonary disease deemed significant enough to be a limitation to exercise - Greater than moderate stenotic or regurgitant valvular heart disease - Presence of atrial fibrillation or other uncontrolled arrhythmias - Uncompensated heart failure - Continuously paced rhythms - Pregnant females - Chronic nitroglycerine use (oral isosorbide di or mono-nitrate, or topical nitroglycerine) - Phosphodiesterase inhibitor (sildenafil or tadalafil) use within a week |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Brooke Army Medical Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | steady state exercise oxygen consumption | Subjects performed steady state treadmill walking at a pre-determine submaximal workload. Oxygen consumption was measured for the last 10 minutes. | 10 minutes | No |
Primary | six minute walk distance | subjects walked at their chosen pace for six minutes on a pre-determined course. Total distance was recorded. | six minutes | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02026102 -
A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)
|
N/A | |
Active, not recruiting |
NCT00949676 -
DECIDE-HF: Heart Rate Variability in Heart Failure Patients
|
N/A | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Recruiting |
NCT05230732 -
Neuromodulation of Inflammation and Endothelial Function
|
N/A | |
Completed |
NCT04065893 -
Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
|
||
Completed |
NCT02946853 -
Junctional AV Ablation in CRT-D: JAVA-CRT
|
N/A | |
Completed |
NCT00833352 -
Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device
|
N/A | |
Terminated |
NCT02958098 -
My Research Legacy Pilot Study
|
||
Enrolling by invitation |
NCT03984591 -
A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
|
Phase 4 | |
Completed |
NCT02156583 -
Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
|
||
Recruiting |
NCT01566344 -
Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes
|
N/A | |
Withdrawn |
NCT01127334 -
Pilot Study Using Echocardiography to Evaluate Patients With Heart Failure and Dyssynchrony Who Have a CRT-D Device
|
N/A | |
Completed |
NCT03534297 -
Study of Dapansutrile Capsules in Heart Failure
|
Phase 1 | |
Completed |
NCT01765400 -
Platelet Inhibition in Patients With Systolic Heart Failure
|
Phase 4 | |
Completed |
NCT01814319 -
Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure
|
Phase 2 | |
Recruiting |
NCT02637167 -
GutHeart: Targeting Gut Microbiota to Treat Heart Failure
|
Phase 2 | |
Suspended |
NCT03755570 -
How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
|
||
Completed |
NCT02084992 -
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
|
N/A | |
Completed |
NCT04937790 -
Effects of Postural Balance Exercises in Patients With Heart Failure
|
N/A | |
Completed |
NCT04019314 -
Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)
|
N/A |